Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized as progressive and irreversible fibrosis in the interstitium of lung tissues. There is still an unmet need to develop a novel therapeutic drug for IPF. We have previously demonstrated that periostin, a matricellular protein,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Respir Cell Mol Biol
Päätekijät: Nanri, Yasuhiro, Nunomura, Satoshi, Terasaki, Yasuhiro, Yoshihara, Tomohito, Hirano, Yusuke, Yokosaki, Yasuyuki, Yamaguchi, Yukie, Feghali-Bostwick, Carol, Ajito, Keiichi, Murakami, Shoichi, Conway, Simon J., Izuhara, Kenji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Thoracic Society 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993541/
https://ncbi.nlm.nih.gov/pubmed/31505128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2019-0245OC
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia